Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine

Duffy, Anne; Milin, Robert; Grof, Paul
January 2009
BMC Psychiatry;2009, Vol. 9, Special section p1
Academic Journal
Background: The purpose of the study was to determine the effectiveness and tolerability of quetiapine as a maintenance treatment preventing against relapse or recurrence of acute mood episodes in adolescent patients diagnosed with bipolar disorder. Methods: Consenting patients meeting DSM-IV lifetime criteria for a bipolar disorder and clinically appropriate for maintenance treatment were enrolled in a 48-week open prospective study. After being acutely stabilized (CGI-S ≤ 3 for 4 consecutive weeks), patients were started or continued on quetiapine and other medications were weaned off over an 8-week period. Quetiapine monotherapy was continued for 40-weeks and other mood stabilizers or antidepressants were added if clinically indicated. A neurocognitive test battery assessing the most reliable findings in adult patients was administered at fixed time points throughout the study to patients and matched controls. Results: Of the 21 enrolled patients, 18 completed the 48-week study. Thirteen patients were able to be maintained without relapse or recurrence in good quality remission on quetiapine monotherapy, while 5 patients required additional medication to treat impairing residual depressive and/or anxiety symptoms. According to symptom ratings and global functioning scores, the quality of remission for all patients was very good. Neurocognitive test performance over treatment was equivalent to that of a matched control group of never ill adolescents. Quetiapine was generally well tolerated with no serious adverse effects. Conclusion: This study suggests that a proportion of adolescent patients diagnosed with bipolar disorder can be successfully maintained on quetiapine monotherapy. The good quality of clinical remission and preserved neurocognitive functioning underscores the importance of early diagnosis and effective stabilization. Clinical Trials Registry: D1441L00024


Related Articles

  • Validation of the Finnish version of the SCOFF questionnaire among young adults aged 20 to 35 years. Lähteenmäki, Sini; Aalto-Setälä, Terhi; Suokas, Jaana T.; Saarni, Suoma E.; Perälä, Jonna; Saarni, Samuli I.; Aro, Hillevi; Lönnqvist, Jouko; Suvisaari, Jaana M. // BMC Psychiatry;2009, Vol. 9, Special section p1 

    Background: We tested the validity of the SCOFF, a five-question screening instrument for eating disorders, in a general population sample. Methods: A random sample of 1863 Finnish young adults was approached with a questionnaire that contained several screens for mental health interview,...

  • The Strengths Perspective: Fortigenesis in Adult Life. Strümpfer, D. J. W. // Social Indicators Research;May2006, Vol. 77 Issue 1, p11 

    “Fortigenesis” (L. fortis=strong) refers to a process of developing strengths at a variety of endpoints. Assumptions are: (i) there exist 2 continua, of mental illness and mental health, along which waxing and waning in the process of fortigenesis moves individuals in the directions...

  • Emerging Options in the Treatment of Bipolar Disorders. Berk, M.; Segal, J.; Janet, L.; Vorster, M. // Drugs;Jul2001, Vol. 61 Issue 10, p1407 

    Bipolar disorder is a common and severe condition, and has a clinical outcome that is frequently sub-optimal. Only a small number of therapeutic options are currently available for the disorder. A growing range of novel therapeutic options for the treatment of bipolar disorder are under...

  • International Commentary of Pediatric Bipolar Disorder. Saxena, Kirti // Journal of the Canadian Academy of Child & Adolescent Psychiatry;2009, Vol. 18 Issue 3, p198 

    The article discusses various reports published within the issue including the phenomenology and pathophysiology of patients with pediatric bipolar disorder (PBD), the effectiveness of diagnostic and statistical manual of mental disorders (DSM-IV) method for PBD treatment and importance of...

  • ALPHABETICAL INDEX.  // Monthly Prescribing Reference;Jun2015, Vol. 31 Issue 6, p297 

    An appendix is presented of therapeutic drugs for several illnesses including the Abilify for bipolar disorder, the Anzemet for anxiety and the Arthrotec for arthritis.

  • Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service. Paterniti, Sabrina; Bisserbe, Jean-Claude // BMC Psychiatry;2013, Vol. 13 Issue 1, p1 

    Background: Many new approaches have been adopted for the treatment of bipolar disorder (BD) in the past few years, which strived to produce more positive outcomes. To enhance the quality of care, several guideline recommendations have been developed. For study purposes, we monitored the...

  • Managing lithium therapy. Gregory, Tanya; Gelenberg, Alan J. // Patient Care;11/30/1995, Vol. 29 Issue 19, p71 

    Focuses on lithium therapy for treatment of bipolar disorders. Reasons why lithium is the first-line treatment for bipolar patients; How to initiate therapy; What to do at follow-up visits; How to monimize lithium toxicity; When to watch for drug interactions; Other therapies for bipolar...

  • Lithium therapy for bipolar disorders.  // Patient Care;11/30/1995, Vol. 29 Issue 19, p90 

    Presents a diagram on how to use lithium therapy for patients with bipolar disorders.

  • Lithium in bipolar disorder: can drug concentrations predict therapeutic effect? Sproule, B.; Sproule, Beth // Clinical Pharmacokinetics;Jul2002, Vol. 41 Issue 9, p639 

    The evidence is reviewed for effective serum lithium concentrations for the acute and prophylactic treatment of mania and depression in patients with bipolar disorder. The efficacy of lithium in the treatment of acute manic episodes has been recognised for several decades, primarily using...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics